LATISSE®
All images © 2020 Allergan
LATISSE®
All images © 2020 Allergan
Indications, Important Safety Information and Prescribing Information
LATISSE® (bimatoprost
ophthalmic solution) 0.03% Important Information
Indication
LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat
hypotrichosis of the eyelashes by increasing their growth, including length,
thickness, and darkness.
Important Safety Information
Contraindications: LATISSE® is
contraindicated in patients with hypersensitivity to bimatoprost or to any of
the ingredients.
Warnings and Precautions: In patients using LUMIGAN® (bimatoprost
ophthalmic solution) or other prostaglandin analogs for the treatment of
elevated intraocular pressure (IOP), the concomitant use of LATISSE® may
interfere with the desired reduction in IOP. Patients using prostaglandin
analogs including LUMIGAN® for
IOP reduction should only use LATISSE® after
consulting with their physician and should be monitored for changes to their
intraocular pressure.
Increased iris pigmentation has occurred when bimatoprost
solution was administered. Patients should be advised about the potential for
increased brown iris pigmentation, which is likely to be permanent.
Bimatoprost has been reported to cause pigment changes
(darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is
expected to increase as long as bimatoprost is administered, but has been
reported to be reversible upon discontinuation of
bimatoprost in most patients.
There is the potential for hair growth to occur in areas
where LATISSE® solution
comes in repeated contact with skin surfaces. Apply LATISSE® only
to the skin of the upper eyelid margin at the base of the eyelashes.
LATISSE® solution should be used with caution in patients with active intraocular
inflammation (eg, uveitis) because the inflammation may be exacerbated. LATISSE® should
be used with caution in aphakic patients, in pseudophakic patients with a torn
posterior lens capsule, or in patients with known risk factors for macular
edema.
Adverse Reactions: The most frequently reported adverse events were eye pruritus,
conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye
symptoms, and periorbital erythema. These reactions occurred in less than 4% of
patients.
Postmarketing Experience: The following adverse reactions have been identified during
postapproval use of LATISSE®:
dry skin of the eyelid and/or periocular area, eye swelling, eyelid edema,
hypersensitivity (local allergic reactions), lacrimation increased, madarosis
and trichorrhexis (temporary loss of a few eyelashes to loss of sections of
eyelashes, and temporary eyelash breakage, respectively), periorbital and lid
changes associated with a deepening of the eyelid sulcus, rash (including
macular and erythematous), skin discoloration (periorbital), and vision
blurred.
Please see LATISSE® full Prescribing Information.
Ditch the Filters—Get Real Results for Your Lashes & Brows
Forget eyelash extensions, brow lamination, or Instagram filters. At Johns Creek Dermatology, we help you unlock the full potential of your natural lashes, brows, and hair with clinically proven, non-surgical treatments—prescribed and monitored by board-certified dermatologists. Whether you're hoping for longer lashes, fuller brows, or a more youthful, defined appearance, we offer personalized solutions for real, lasting results.
Physician-Prescribed Treatments for Lashes & Brows
We proudly serve patients across Johns Creek and the Greater Atlanta area with a curated selection of safe and effective treatment options for lash and brow enhancement.
These include:
• Latisse®
• FUE Hair Transplant for permanent brow restoration (for appropriate candidates)
Each treatment is chosen specifically for your goals, hair type, and tolerance, with expert guidance from our medical team.
Serum Options for Thick and Fuller Look
Latisse® FDA-Approved Lash Growth
Wish your lashes were naturally thicker, longer, and darker? Latisse® is an FDA-approved prescription treatment that enhances eyelash growth within weeks. It works by extending the growth phase of your lashes, and with regular use, you’ll see real, measurable results—no falsies required. Ask our team if you’re a good candidate for Latisse.
Neulash® & Neubrow®: Botanical Boosts for Brows & Lashes
If you’re looking for a gentler, non-prescription approach, Neulash® and Neubrow® offer powerful blends of botanicals, peptides, and antioxidants to nourish and strengthen the hair follicle. Patients often notice fuller, healthier-looking lashes and brows in just a few weeks of consistent use. Ideal for those wanting to enhance without medications.
Want Fuller Brows Permanently?
For patients with sparse or over-plucked brows, we also offer brow hair transplants using the same precision techniques used in scalp restoration. This procedure creates permanent, natural-looking brows that follow your desired shape and density.
Book Your Medical Hair Loss Consultation for Brows & Lashes
At Johns Creek Dermatology, we treat thinning brows and lashes with evidence-based, physician-prescribed solutions
LATISSE®
All images © 2020 Allergan
Indications, Important Safety Information and Prescribing Information
LATISSE® (bimatoprost
ophthalmic solution) 0.03% Important Information
Indication
LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat
hypotrichosis of the eyelashes by increasing their growth, including length,
thickness, and darkness.
Important Safety Information
Contraindications: LATISSE® is
contraindicated in patients with hypersensitivity to bimatoprost or to any of
the ingredients.
Warnings and Precautions: In patients using LUMIGAN® (bimatoprost
ophthalmic solution) or other prostaglandin analogs for the treatment of
elevated intraocular pressure (IOP), the concomitant use of LATISSE® may
interfere with the desired reduction in IOP. Patients using prostaglandin
analogs including LUMIGAN® for
IOP reduction should only use LATISSE® after
consulting with their physician and should be monitored for changes to their
intraocular pressure.
Increased iris pigmentation has occurred when bimatoprost
solution was administered. Patients should be advised about the potential for
increased brown iris pigmentation, which is likely to be permanent.
Bimatoprost has been reported to cause pigment changes
(darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is
expected to increase as long as bimatoprost is administered, but has been
reported to be reversible upon discontinuation of
bimatoprost in most patients.
There is the potential for hair growth to occur in areas
where LATISSE® solution
comes in repeated contact with skin surfaces. Apply LATISSE® only
to the skin of the upper eyelid margin at the base of the eyelashes.
LATISSE® solution should be used with caution in patients with active intraocular
inflammation (eg, uveitis) because the inflammation may be exacerbated. LATISSE® should
be used with caution in aphakic patients, in pseudophakic patients with a torn
posterior lens capsule, or in patients with known risk factors for macular
edema.
Adverse Reactions: The most frequently reported adverse events were eye pruritus,
conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye
symptoms, and periorbital erythema. These reactions occurred in less than 4% of
patients.
Postmarketing Experience: The following adverse reactions have been identified during
postapproval use of LATISSE®:
dry skin of the eyelid and/or periocular area, eye swelling, eyelid edema,
hypersensitivity (local allergic reactions), lacrimation increased, madarosis
and trichorrhexis (temporary loss of a few eyelashes to loss of sections of
eyelashes, and temporary eyelash breakage, respectively), periorbital and lid
changes associated with a deepening of the eyelid sulcus, rash (including
macular and erythematous), skin discoloration (periorbital), and vision
blurred.
Please see LATISSE® full Prescribing Information.
